Mangoceuticals, Inc. (MGRX) Stock Overview
Explore Mangoceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Mangoceuticals, Inc. (MGRX)
Key Financials
Key Financials
Market Cap
3.6M
P/E Ratio
-0.19
EPS (TTM)
$-1.27
ROE
-1.21%
MGRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mangoceuticals, Inc. (MGRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.19 and a market capitalization of 3.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.